Business Context and Reporting Period
Company: Iridium Communications Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 8, 2014 (Event Date)
Reporting Period: Specific event date; not a periodic financial report.
Key Financial Metrics and Transaction Details
This filing details a dual capital raise event rather than operational financial performance. Key metrics include:
- Common Stock Offering: 7,377,050 shares at $6.10 per share (public price); $5.795 per share (underwriter purchase price).
- Preferred Stock Offering: 500,000 shares of 6.75% Series B Cumulative Perpetual Convertible Preferred Stock at $250 per share (public price); $242.50 per share (underwriter purchase price).
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 1,106,558 additional common shares at $5.795 per share.
- Expected Gross Proceeds: Approximately $170 million (excluding underwriting discounts, expenses, and potential over-allotment exercise).
- Intended Use of Proceeds: General corporate purposes, capital expenditures, working capital, and general and administrative expenses.
Note: The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes Versus Prior Period
The filing does not present comparative financial data or operational changes versus a prior period. The material change is the entry into definitive underwriting agreements for a significant equity and preferred stock offering.
Guidance, Outlook, and Risks
- Closing Date: Offerings expected to close on or about May 14, 2014, subject to customary closing conditions.
- Underwriters:
- Common Shares: Raymond James, Deutsche Bank Securities, and William Blair (joint book-running managers).
- Preferred Shares: Deutsche Bank Securities and Raymond James (joint book-running managers); Canaccord Genuity and Societe Generale (co-managers).
- Risks/Contingencies: Proceeds are contingent on the closing of the offerings and the potential exercise of the over-allotment option. The filing includes standard disclaimers regarding the legality of offers in various jurisdictions.
Investor Verification Checklist
- Verify the final closing date of the offerings (expected May 14, 2014).
- Confirm whether the underwriters exercised the 30-day over-allotment option for 1,106,558 additional common shares.
- Review the definitive Underwriting Agreements (Exhibits 1.1 and 1.2) for specific covenants and redemption terms of the 6.75% Series B Preferred Stock.
- Monitor subsequent filings for the actual net proceeds received after deducting underwriting discounts and offering expenses.